- Home
- Publications
- Publication Search
- Publication Details
Title
Repurposing medicinal compounds for blood cancer treatment
Authors
Keywords
Blood cancer, Drug repurposing, Review
Journal
ANNALS OF HEMATOLOGY
Volume 94, Issue 8, Pages 1267-1276
Publisher
Springer Nature
Online
2015-06-06
DOI
10.1007/s00277-015-2412-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase 2 trial of dasatinib in target-selected patients with recurrent glioblastoma (RTOG 0627)
- (2015) Andrew B. Lassman et al. NEURO-ONCOLOGY
- Novel Modeling of Cancer Cell Signaling Pathways Enables Systematic Drug Repositioning for Distinct Breast Cancer Metastases
- (2013) H. Zhao et al. CANCER RESEARCH
- Toward better drug repositioning: prioritizing and integrating existing methods into efficient pipelines
- (2013) Guangxu Jin et al. DRUG DISCOVERY TODAY
- Molecular-targeted agents combination therapy for cancer: Developments and potentials
- (2013) Feifei Li et al. INTERNATIONAL JOURNAL OF CANCER
- 2012 FDA drug approvals
- (2013) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Molecularly targeted cancer therapy: some lessons from the past decade
- (2013) Min Huang et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Drug Repurposing: Far Beyond New Targets for Old Drugs
- (2012) T. I. Oprea et al. AAPS Journal
- Drug repurposing in pediatrics and pediatric hematology oncology
- (2012) Julie Blatt et al. DRUG DISCOVERY TODAY
- Off-Label Use of Oncology Drugs: The Need for More Data and Then Some
- (2012) David G. Pfister JOURNAL OF CLINICAL ONCOLOGY
- New sources of drugs for hematologic malignancies
- (2011) M. A. Sukhai et al. BLOOD
- Database identifies FDA-approved drugs with potential to be repurposed for treatment of orphan diseases
- (2011) K. Xu et al. BRIEFINGS IN BIOINFORMATICS
- Mining small-molecule screens to repurpose drugs
- (2011) S. J. Swamidass BRIEFINGS IN BIOINFORMATICS
- Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network
- (2011) A Smith et al. BRITISH JOURNAL OF CANCER
- A Novel Method of Transcriptional Response Analysis to Facilitate Drug Repositioning for Cancer Therapy
- (2011) G. Jin et al. CANCER RESEARCH
- The NCGC Pharmaceutical Collection: A Comprehensive Resource of Clinically Approved Drugs Enabling Repurposing and Chemical Genomics
- (2011) R. Huang et al. Science Translational Medicine
- PCN112 OFF-LABEL USE OF ONCOLOGY DRUGS IN A COMMUNITY ONCOLOGY EMR DATABASE
- (2011) R Stephen et al. VALUE IN HEALTH
- Stage 2 Combination Testing of Rapamycin with Cytotoxic Agents by the Pediatric Preclinical Testing Program
- (2010) P. J. Houghton et al. MOLECULAR CANCER THERAPEUTICS
- Drug Discovery Using Chemical Systems Biology: Repositioning the Safe Medicine Comtan to Treat Multi-Drug and Extensively Drug Resistant Tuberculosis
- (2009) Sarah L. Kinnings et al. PLoS Computational Biology
- A simple and robust method for connecting small-molecule drugs using gene-expression signatures
- (2008) Shu-Dong Zhang et al. BMC BIOINFORMATICS
- Phase II, Open-Label Study Evaluating the Activity of Imatinib in Treating Life-Threatening Malignancies Known to Be Associated with Imatinib-Sensitive Tyrosine Kinases
- (2008) M. C. Heinrich et al. CLINICAL CANCER RESEARCH
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started